Staging of brain pathology related to sporadic Parkinson’s disease

Baba, 1998, Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies, Am. J. Pathol., 152, 879 Bergeron C, Pollanen MS. Pathogenesis of the Lewy body. In: Perry RH, McKeith IG, Perry EK, editors. Dementia with Lewy bodies. Cambridge, NY: Cambridge University Press, 1996. p. 302–7. Braak, 1999, Silver staining method for demonstrating Lewy bodies in Parkinson’s disease and argyrophilic oligodendrocytes in multiple system atrophy, J. Neurosci. Methods, 87, 111, 10.1016/S0165-0270(98)00173-3 Braak H. Architectonics as seen by lipofuscin stains. In: Jones EG, Peters A, editors. Cerebral cortex. Cellular components of the cerebral cortex, vol. 1. London: Plenum Press, 1984. p. 59–104. Braak, 1986, Nuclear configuration and neuronal types of the nucleus niger in the brain of the human adult, Hum. Neurobiol., 5, 71 Braak, 1991, Neuropathological staging of Alzheimer-related changes, Acta Neuropathol., 82, 239, 10.1007/BF00308809 Braak, 1991, Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections, Brain Pathol., 1, 213, 10.1111/j.1750-3639.1991.tb00661.x Braak, 1992, The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases, Neurosci. Res., 15, 6, 10.1016/0168-0102(92)90014-4 Braak, 1997, Frequency of stages of Alzheimer-related lesions in different age categories, Neurobiol. Aging, 18, 351, 10.1016/S0197-4580(97)00056-0 Braak, 2000, Pathoanatomy of Parkinson’s disease, J. Neurol., 247, 3 Braak, 1994, Amygdala pathology in Parkinson’s disease, Acta Neuropathol., 88, 493, 10.1007/BF00296485 Braak H, Braak E, Yilmazer D, Schultz C, Bohl J. Age-related changes of the human cerebral cortex. In: Cruz-Sanchez FF, Ravid R, Cuzner ML, editors. Neuropathological diagnostic criteria for brain banking. Biomedical health research, vol. 10. Amsterdam: IOS Press 1995;19:14–9. Braak, 2000, Parkinson’s disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system, Acta Neuropathol., 99, 489, 10.1007/s004010051150 Braak, 2000, Pathological changes in the parahippocampal region in select non-Alzheimer dementias, Ann. N. Y. Acad. Sci., 911, 221, 10.1111/j.1749-6632.2000.tb06729.x Braak, 2000, Alpha-synuclein is not a requisite component of synaptic boutons in the adult human central nervous system, J. Chem. Neuroanat., 20, 245, 10.1016/S0891-0618(00)00101-0 Calne, 1992, Criteria for diagnosing Parkinson’s disease, Ann. Neurol., 32, 125, 10.1002/ana.410320721 Cochran, 1954, Some methods for strengthening the common c2-tests, Biometrics, 10, 417, 10.2307/3001616 Dale, 1993, Relationship between Lewy bodies and pale bodies in Parkinson’s disease, Acta Neuropathol., 83, 525, 10.1007/BF00310030 Damier, 1999, The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry, Brain, 122, 1421, 10.1093/brain/122.8.1421 Damier, 1999, The substantia nigra of the human brain. II. Patterns of loss of dopaminergic neurons in Parkinson’s disease, Brain, 122, 1437, 10.1093/brain/122.8.1437 Delwaide, 1993, The audiospinal reaction in parkinsonian patients reflects functional changes in reticular nuclei, Ann. Neurol., 33, 63, 10.1002/ana.410330111 de Vos, 1995, Lewy body disease: clinico-pathological correlations in 18 consecutive cases of Parkinson’s disease with and without dementia, Clin. Neurol. Neurosurg., 97, 13, 10.1016/0303-8467(94)00060-J de Vos RAI, Jansen Steur ENH, Yilmazer D, Braak H, Braak E. Pathological and clinical features of Parkinson’s disease with and without dementia. In: Perry RH, McKeith IG, Perry EK, editors. Dementia with Lewy bodies. Cambridge, NY: Cambridge University Press, 1996. p. 255–67 Del Tredici, 2002, Where does Parkinson disease pathology begin in the brain?, J. Neuropathol. Exp. Neurol., 61, 413, 10.1093/jnen/61.5.413 Dickson DW. Aging in the central nervous system. In: Markesbery WR, editor. Neuropathology of dementing disorders. London: Arnold, 1998. p. 56–88. Dickson, 1999, Tau and synuclein and their role in neuropathology, Brain Pathol., 9, 657, 10.1111/j.1750-3639.1999.tb00548.x Dickson, 1991, Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer’s disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD, Neurology, 41, 1402, 10.1212/WNL.41.9.1402 Dickson, 1994, Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease, Acta Neuropathol., 87, 269, 10.1007/BF00296742 Dubois, 1997, Cognitive deficits in Parkinson’s disease, J. Neurol., 244, 2, 10.1007/PL00007725 Duda, 2000, Neuropathology of synuclein aggregates: new insights into mechanism of neurodegenerative diseases, J. Neurosci. Res., 61, 121, 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4 Fahn S. Parkinson’s disease and other basal ganglion disorders. In: Asbury AK, McKhann GM, McDonald WI, editors. Diseases of the nervous system: clinical neurobiology, vol. 1. Philadelphia: Saunders, 1992. p. 1144–58. Fearnley J, Lees AJ. Pathology of Parkinson’s disease. In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: Saunders, 1991. p. 545–54. Forno, 1969, Concentric hyalin intraneuronal inclusions of Lewy type in the brain of elderly persons (50 incidental cases): relationship to parkinsonism, J. Am. Geriatr. Soc., 17, 557, 10.1111/j.1532-5415.1969.tb01316.x Forno, 1996, Neuropathology of Parkinson’s disease, J. Neuropathol. Exp. Neurol., 55, 259, 10.1097/00005072-199603000-00001 Gai, 1999, Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components, J. Neurochem., 73, 2093 Galvin, 2001, Synucleinopathies. Clinical and pathological implications, Arch. Neurol., 58, 186, 10.1001/archneur.58.2.186 Geisler, 2000, Event-related brain potentials to attended and ignored olfactory and trigeminal stimuli, Int. J. Psychophysiol., 37, 309, 10.1016/S0167-8760(00)00111-2 Gelb, 1999, Diagnostic criteria for Parkinson’s disease, Arch. Neurol., 56, 33, 10.1001/archneur.56.1.33 Gibb, 1991, Neuropathology of the substantia nigra, Eur. Neurol., 31, 48, 10.1159/000116721 Gibb, 1991, Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson’s disease, J. Neurol. Neurosurg. Psychiatry, 54, 388, 10.1136/jnnp.54.5.388 Gibb, 1991, Neuronal inclusions of Parkinson’s disease, Mov. Disord., 6, 2, 10.1002/mds.870060103 Goedert, 2001, The significance of tau and α-synuclein inclusions in neurodegenerative diseases, Curr. Opin. Genet. Dev., 11, 343, 10.1016/S0959-437X(00)00200-8 Goetz, 1986, Autonomic dysfunction in Parkinson’s disease, Neurology, 36, 73, 10.1212/WNL.36.1.73 Hassler, 1937, Zur Normalanatomie der Substantia nigra. Versuch einer architektonischen Gliederung, J. Psychol. Neurol., 48, 1 Hassler, 1938, Zur Pathologie der paralysis agitans und des postencephalitischen Parkinsonismus, J. Psychol. Neurol., 48, 387 Hawkes, 1997, Olfactory dysfunction in Parkinson’s disease, J. Neurol. Neurosurg. Psychiatry, 62, 436, 10.1136/jnnp.62.5.436 Hawkes, 1999, Is Parkinson’s disease a primary olfactory disorder?, Q. J. Med., 92, 473, 10.1093/qjmed/92.8.473 Hoehn, 1967, Parkinsonism: onset, progression, and mortality, Neurology, 17, 427, 10.1212/WNL.17.5.427 Hyman, 1998, New neuropathological criteria for Alzheimer’s disease, Arch. Neurol., 55, 1174, 10.1001/archneur.55.9.1174 Irizarry, 1998, Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson’s disease and cortical Lewy body disease contain α-synuclein immunoreactivity, J. Neuropathol. Exp. Neurol., 57, 334, 10.1097/00005072-199804000-00005 Jellinger, 1991, Pathology of Parkinson’s disease. Changes other than the nigrostriatal pathway, Mol. Chem. Neuropathol., 14, 153, 10.1007/BF03159935 Koller, 1992, When does Parkinson’s disease begin?, Neurology, 42, 27 Korczyn, 1990, Autonomic nervous system disturbances in Parkinson’s disease, Adv. Neurol., 53, 463 Lewy FH. Paralysis agitans. I. Pathologische Anatomie. In: Lewandowski M, editor. Handbuch der Neurologie, Band III. Berlin: Springer, 1912. p. 920–33. Lowe J. Lewy bodies. In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: Saunders, 1994. p. 51–69. Loza, 1997, Functional changes of brainstem reflexes in Parkinson’s disease. Conditioning of blink reflex R2 component by paired and index finger stimulation, J. Neural Transm., 104, 679, 10.1007/BF01291885 Meco, 1991, Cardiovascular reflexes and autonomic dysfunction in Parkinson’s disease, J. Neurol., 238, 195, 10.1007/BF00314779 Mesholam, 1998, Olfaction in neurodegenerative disease. A meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases, Arch. Neurol., 55, 84, 10.1001/archneur.55.1.84 Pearce, 1995, The anterior olfactory nucleus in Parkinson’s disease, Mov. Disord., 10, 283, 10.1002/mds.870100309 Perry, 1990, Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei, J. Neurol. Sci., 100, 223, 10.1016/0022-510X(90)90037-N Pollanen, 1993, Pathology and biology of the Lewy body, J. Neuropathol. Exp. Neurol., 52, 183, 10.1097/00005072-199305000-00001 Price JL. Olfactory system. In: Paxinos G, editor. The human nervous system. San Diego: Academic Press, 1990. p. 979–1000. Rajput AH. Clinical features and natural history of Parkinson’s disease (special consideration of aging). In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: Saunders, 1994. p. 555–71. Rüb, 2002, Parkinson’s disease: the thalamic components of the limbic loop are severely impaired by α-synuclein immunopositive inclusion body pathology, Neurobiol. Aging, 23, 245, 10.1016/S0197-4580(01)00269-X Sakuma, 1996, Olfactory evoked potentials in Parkinson’s disease, Alzheimer’s disease and anosmic patients, Psychiatr. Clin. Neurosci., 50, 35, 10.1111/j.1440-1819.1996.tb01660.x Sandmann-Keil, 1999, Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson’s disease are detectable by an advanced silver-staining technique, Acta Neuropathol., 98, 461, 10.1007/s004010051110 Sawle, 1993, The detection of preclinical Parkinson’s disease: what is the role of positron emission tomography?, Mov. Disord., 8, 271, 10.1002/mds.870080304 Trojanowski, 1998, Aggregation of neurofilament and α-synuclein proteins in Lewy bodies—implications for the pathogenesis of Parkinson-disease and Lewy body dementia, Arch. Neurol., 55, 151, 10.1001/archneur.55.2.151 Valls-Solé, 2000, Neurophysiological characterization of parkinsonian syndromes, Neurophysiol. Clin., 30, 352, 10.1016/S0987-7053(00)00236-7 Wakabayashi, 1995, Cortical Lewy body-containing neurons are pyramidal cells. Laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32, Acta Neuropathol., 89, 404, 10.1007/BF00307643 Wakabayashi, 1992, Immunocytochemical localization of synaptic vesicle-specific protein in Lewy body-containing neurons in Parkinson’s disease, Neurosci. Lett., 138, 237, 10.1016/0304-3940(92)90923-U Wolters, 2000, Preclinical (premotor) Parkinson’s disease, J. Neurol., 247, 103